search
Back to results

Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life (VitDBR2012)

Primary Purpose

Acute Bronchitis, Upper Respiratory Tract Infection, Acute Bronchiolitis

Status
Completed
Phase
Phase 3
Locations
Spain
Study Type
Interventional
Intervention
Vitamin D3
Placebo
Sponsored by
Hospital Universitari Vall d'Hebron Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Acute Bronchitis focused on measuring Vitamin D, Acute bronchitis, Upper respiratory tract infection, Recurrent bronchitis, Acute bronchiolitis, Infants

Eligibility Criteria

undefined - 19 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Healthy term born infants of appropriate size for gestational age
  • Parents provide informed consent to participate

Exclusion Criteria:

  • Infants with small size for gestational age
  • Infants with gestational age < 37 weeks
  • Infants with congenital anomalies
  • Infants with chronic gastrointestinal tract, liver, kidney, heart, or neurological diseases
  • Infants with disorders of vitamin D or calcium metabolism or others inborn errors of metabolism

Sites / Locations

  • Hospital Universitary Vall d'Hebron

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Vitamin D3 1000 IU/day

Vitamin D3 400 IU/day

Arm Description

Infants will be supplemented with vitamin D and/or placebo to receive a total amount of vitamin D3 of 1.000 IU/day during the first year of life, taking into account the vitamin D received with artificial milk

Infants will be supplemented with vitamin D and/or placebo to receive a total amount of vitamin D3 of 400 IU/day during the first year of life, taking into account the vitamin D received with artificial milk

Outcomes

Primary Outcome Measures

Percentage of children with acute bronchitis
Check that the administration of a vitamin D dose of 1,000 U / day decreases the percentage of children with acute bronchitis during the first year of life

Secondary Outcome Measures

Number of episodes of upper respiratory infections reported by parents in the first year of life
Check that the supplementation of vitamin D of 1,000 units / day decreases the number of upper respiratory infections

Full Information

First Posted
June 10, 2013
Last Updated
March 21, 2017
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT01875757
Brief Title
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
Acronym
VitDBR2012
Official Title
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Universitari Vall d'Hebron Research Institute

4. Oversight

5. Study Description

Brief Summary
A phase III multicenter randomized double blind clinical trial will be conducted. After obtaining written consent the infant will be randomized, during the first two weeks of life, to a study group to receive either 400 IU or 1,000 IU / day of vitamin D to the year of age. Baseline and all follow up visits (2, 6, and 12 months of life) will include anthropometric measurements and a questionnaire about health issues. A blood sample will be obtained at baseline for analysis of 25OH vitamin D, and at 6 and 12 months for analysis of 25 OH vitamin D, and calcium. Healthy term born infants of appropriate size for gestational age will be included. We will need to include 359 children in each group. The primary objective of the study is to decrease the proportion of infants with acute bronchitis during the first year of life by supplementation of 1,000 IU/day vitamin D. Secondary otcomes are: To check that the administration of 1,000 IU/day vitamin D decreases the proportion of infants with upper respiratory tract infections, the proportion of children under one year of age hospitalized for acute bronchiolitis, and the demand on the healthcare system due to respiratory infections and absences from work for parents and achieves a higher proportion of children with adequate blood levels 25 OH vitamin D.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Bronchitis, Upper Respiratory Tract Infection, Acute Bronchiolitis
Keywords
Vitamin D, Acute bronchitis, Upper respiratory tract infection, Recurrent bronchitis, Acute bronchiolitis, Infants

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Vitamin D3 1000 IU/day
Arm Type
Experimental
Arm Description
Infants will be supplemented with vitamin D and/or placebo to receive a total amount of vitamin D3 of 1.000 IU/day during the first year of life, taking into account the vitamin D received with artificial milk
Arm Title
Vitamin D3 400 IU/day
Arm Type
Active Comparator
Arm Description
Infants will be supplemented with vitamin D and/or placebo to receive a total amount of vitamin D3 of 400 IU/day during the first year of life, taking into account the vitamin D received with artificial milk
Intervention Type
Drug
Intervention Name(s)
Vitamin D3
Intervention Type
Drug
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
Percentage of children with acute bronchitis
Description
Check that the administration of a vitamin D dose of 1,000 U / day decreases the percentage of children with acute bronchitis during the first year of life
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Number of episodes of upper respiratory infections reported by parents in the first year of life
Description
Check that the supplementation of vitamin D of 1,000 units / day decreases the number of upper respiratory infections
Time Frame
1 year
Other Pre-specified Outcome Measures:
Title
Percentage of children with recurrent bronchitis
Description
Check that the supplementation of vitamin D of 1,000 units / day decreases the number of recurrent bronchitis
Time Frame
1 year

10. Eligibility

Sex
All
Maximum Age & Unit of Time
19 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Healthy term born infants of appropriate size for gestational age Parents provide informed consent to participate Exclusion Criteria: Infants with small size for gestational age Infants with gestational age < 37 weeks Infants with congenital anomalies Infants with chronic gastrointestinal tract, liver, kidney, heart, or neurological diseases Infants with disorders of vitamin D or calcium metabolism or others inborn errors of metabolism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio Moreno, MD, PhD
Organizational Affiliation
Hospital Universitari Vall d'hebron Barcelona, Spain
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital Universitary Vall d'Hebron
City
Barcelona
ZIP/Postal Code
08035
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
21187313
Citation
Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, Town GI, Pattemore PK, Espinola JA, Crane J; New Zealand Asthma and Allergy Cohort Study Group. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011 Jan;127(1):e180-7. doi: 10.1542/peds.2010-0442. Epub 2010 Dec 27.
Results Reference
background
PubMed Identifier
21555499
Citation
Belderbos ME, Houben ML, Wilbrink B, Lentjes E, Bloemen EM, Kimpen JL, Rovers M, Bont L. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics. 2011 Jun;127(6):e1513-20. doi: 10.1542/peds.2010-3054. Epub 2011 May 9.
Results Reference
background
PubMed Identifier
18030309
Citation
Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009 Apr;63(4):473-7. doi: 10.1038/sj.ejcn.1602960. Epub 2007 Nov 21.
Results Reference
background
PubMed Identifier
20219962
Citation
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010 May;91(5):1255-60. doi: 10.3945/ajcn.2009.29094. Epub 2010 Mar 10.
Results Reference
background
PubMed Identifier
17344509
Citation
Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, Martindale S, Helms PJ, Seaton A, Weiss ST. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007 Mar;85(3):853-9. doi: 10.1093/ajcn/85.3.853.
Results Reference
background
PubMed Identifier
17344501
Citation
Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, Kleinman K, Gillman MW. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007 Mar;85(3):788-95. doi: 10.1093/ajcn/85.3.788.
Results Reference
background

Learn more about this trial

Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life

We'll reach out to this number within 24 hrs